Basic Information
Basic information for LINC01727-212-15aa-3
Peptide Name LINC01727-212-15aa-3
Genome Position chr20:21612591-21612635[+]
Species Human
Peptide Sequence MYRTGCCLVESVGTE
Peptide Length 15
Unique No (LINC01727-202-15aa-1,LINC01727-203-15aa-2,LINC01727-206-15aa-2,LINC01727-207-15aa,LINC01727-208-15aa,LINC01727-209-15aa,LINC01727-210-15aa-1,LINC01727-211-15aa,LINC01727-213-15aa,LINC01727-214-15aa-1,LINC01727-215-15aa-1,LINC01727-216-15aa,LINC01727-217-15aa)
Grand Average of Hydropathicity 0.22
Relative Molecular Mass 1900.2
Experimental Evidences no
lncRNA ID/Name ENSG00000279082;LINC01727
Transcript ID/Name ENST00000663538;LINC01727-212
Transcript Length 4540
Coding Ability 0.4615
DNA Sequence Corresponding to Peptide ATGTACAGAACTGGTTGCTGCCTCGTTGAGTCGGTGGGGACAGAA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :